FibroBiologics, Inc. (FBLG)
1.36
-0.07
(-4.90%)
USD |
NASDAQ |
Sep 21, 16:00
1.32
-0.04
(-2.94%)
After-Hours: 20:00
FibroBiologics Price : 1.36 for Sept. 21, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 21, 2026 | 1.46 | 1.46 | 1.29 | 1.36 | 116921.0 |
| Sep 18, 2026 | 1.54 | 1.54 | 1.40 | 1.43 | 130704.0 |
| Sep 17, 2026 | 1.53 | 1.587 | 1.46 | 1.485 | 105164.0 |
| Sep 16, 2026 | 1.44 | 1.490 | 1.386 | 1.43 | 117219.0 |
| Sep 15, 2026 | 1.55 | 1.575 | 1.44 | 1.44 | 177211.0 |
| Sep 14, 2026 | 1.60 | 1.690 | 1.521 | 1.55 | 174498.0 |
| Sep 11, 2026 | 1.70 | 1.736 | 1.61 | 1.61 | 107289.0 |
| Sep 10, 2026 | 1.73 | 1.796 | 1.671 | 1.73 | 83791.00 |
| Sep 09, 2026 | 1.73 | 1.80 | 1.62 | 1.76 | 138311.0 |
| Sep 08, 2026 | 1.80 | 1.816 | 1.619 | 1.71 | 166412.0 |
| Sep 04, 2026 | 1.73 | 1.90 | 1.71 | 1.81 | 210456.0 |
| Sep 03, 2026 | 1.80 | 1.900 | 1.70 | 1.76 | 366002.0 |
| Sep 02, 2026 | 2.17 | 2.175 | 1.865 | 1.95 | 639027.0 |
| Sep 01, 2026 | 1.73 | 2.200 | 1.72 | 2.11 | 1.545M |
| Aug 31, 2026 | 1.46 | 1.790 | 1.401 | 1.72 | 508098.0 |
| Aug 28, 2026 | 1.50 | 1.54 | 1.41 | 1.44 | 143785.0 |
| Aug 27, 2026 | 1.44 | 1.52 | 1.42 | 1.49 | 217831.0 |
| Aug 26, 2026 | 1.39 | 1.470 | 1.33 | 1.41 | 164686.0 |
| Aug 25, 2026 | 1.34 | 1.49 | 1.33 | 1.40 | 191303.0 |
| Aug 24, 2026 | 1.42 | 1.50 | 1.31 | 1.35 | 252938.0 |
| Aug 21, 2026 | 1.35 | 1.489 | 1.34 | 1.44 | 570614.0 |
| Aug 20, 2026 | 1.22 | 1.37 | 1.20 | 1.29 | 415523.0 |
| Aug 19, 2026 | 1.17 | 1.28 | 1.14 | 1.19 | 390412.0 |
| Aug 18, 2026 | 1.09 | 1.18 | 1.01 | 1.14 | 303532.0 |
| Aug 17, 2026 | 1.09 | 1.12 | 0.9902 | 1.02 | 118931.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| ACADIA Pharmaceuticals, Inc. | 26.40 |
| Alnylam Pharmaceuticals, Inc. | 244.32 |
| Anika Therapeutics, Inc. | 20.70 |
| Savara, Inc. | 5.45 |
| Vericel Corp. | 39.55 |
Price Related Metrics
| PEG Ratio | -0.0084 |
| Price to Book Value | 1.784 |
| Earnings Yield | -414.7% |
| Market Cap | 8.270M |
| PEGY Ratio | -0.0084 |